POL humane challenge
(Die Seite wurde neu angelegt: „{{up|Politics main page}} *[https://gab.com/cbdfan/posts/105459265721167670 '''2500''' young healthy brits to be vucked, then challenxt]“) |
|||
| (7 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) | |||
| Zeile 1: | Zeile 1: | ||
| − | {{up|Politics main page}} | + | {{up|Politics main page}}{{qt|POL research ethics}} |
| + | |||
| + | Nuremberg was for nazis only and UK is not Europe | ||
*[https://gab.com/cbdfan/posts/105459265721167670 '''2500''' young healthy brits to be vucked, then challenxt] | *[https://gab.com/cbdfan/posts/105459265721167670 '''2500''' young healthy brits to be vucked, then challenxt] | ||
| + | {{tp|p=32218549|t=2020. Should scientists infect healthy people with the coronavirus to test vaccines?|pdf=|usr=018}} | ||
| + | {{tp|p=32241929|t=2020. Infect volunteers to speed a coronavirus vaccine?|pdf=|usr=007}} | ||
| + | {{tp|p=32322034|t=2020. Hundreds of people volunteer to be infected with coronavirus.|pdf=|usr=018}} | ||
| + | {{tp|p=32461245|t=2020. Ethical guidelines for deliberately infecting volunteers with COVID-19.|pdf=|usr=007}} | ||
| + | {{tp|p=32469074|t=2020. Paying Participants in COVID-19 Trials.|pdf=|usr=007}} | ||
| + | {{tp|p=32414757|t=2020. Ethical considerations for epidemic vaccine trials.|pdf=|usr=007}} | ||
| + | {{tp|p=32479747|t=2020. COVID-19 human challenge studies: ethical issues.|pdf=|usr=009}} | ||
| + | {{tp|p=32496536|t=2020. SARS-CoV-2 Human Challenge Trials: Too Risky, Too Soon.|pdf=|usr=007}} | ||
| + | {{tp|p=32635912|t=2020. Exploring the acceptability of controlled human infection with SARSCoV2-a public consultation.|pdf=|usr=012}} | ||
| + | {{tp|p=32669462|t=2020. Human Infection Challenge Studies: a Test for the Social Value Criterion of Research Ethics.|pdf=|usr=014}} | ||
| + | {{tp|p=32616623|t=2020. Controlled human infection with SARS-CoV-2 to study COVID-19 vaccines and treatments: bioethics in Utopia.|pdf=|usr=012}} | ||
| + | {{tp|p=32795408|t=2020. Evolving ethics of COVID-19 challenge trials.|pdf=|usr=019}} | ||
| + | {{tp|p=32851596|t=2020. COVID-19 vaccines: ethical framework concerning human challenge studies.|pdf=|usr=018}} | ||
| + | {{tp|p=32829985|t=2020. SARS-CoV-2 controlled human infection models: Ethics, challenge agent production and regulatory issues.|pdf=|usr=018}} | ||
| + | {{tp|p=32840856|t=2020. Coronavirus Human Infection Challenge Studies: Assessing Potential Benefits and Risks.|pdf=|usr=018}} | ||
| + | {{tp|p=33046591|t=2020. Payment of COVID-19 challenge trials: underpayment is a bigger worry than overpayment.|pdf=|usr=020}} | ||
| + | {{tp|p=32978304|t=2020. SARS-CoV-2 challenge studies: ethics and risk minimisation.|pdf=|usr=019}} | ||
| + | {{tp|p=32978306|t=2020. Payment in challenge studies: ethics, attitudes and a new payment for risk model.|pdf=|usr=019}} | ||
| + | {{tp|p=33082550|t=2020. Dozens to be deliberately infected with coronavirus in UK 'human challenge' trials.|pdf=|usr=020}} | ||
| + | {{tp|p=33087558|t=2020. Opinion: A risk-benefit framework for human research during the COVID-19 pandemic.|pdf=|usr=020}} | ||
| + | {{tp|p=33087904|t=2020. Immunological considerations for SARS-CoV-2 human challenge studies.|pdf=|usr=020}} | ||
| + | {{tp|p=33122444|t=2020. Opinion: For now, it's unethical to use human challenge studies for SARS-CoV-2 vaccine development.|pdf=|usr=020}} | ||
| + | {{tp|p=33137284|t=2020. COVID-19 human challenge studies in the UK.|pdf=|usr=020}} | ||
| + | {{tp|p=33154089|t=2020. Should practice and policy be revised to allow for risk-proportional payment to human challenge study participants?|pdf=|usr=023}} | ||
| + | {{tp|p=33235368|t=2020. The COVID vaccine challenges that lie ahead.|pdf=|usr=021}} | ||
| + | {{tp|p=33236048|t=2020. Challenge Trials: What Are the Ethical Problems?|pdf=|usr=021}} | ||
| + | {{tp|p=33249450|t=2020. Assessment of risks associated with SARS-CoV-2 experimental human infection studies.|pdf=|usr=021}} | ||
| + | {{tp|p=C7598752|t=?. Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group.|pdf=|usr=023}} | ||
| + | {{tp|p=C7239090|t=?. Why We (Probably) Must Deliberately Infect.|pdf=|usr=015}} | ||
Aktuelle Version vom 5. Januar 2021, 20:07 Uhr
| Politics main page |
| POL research ethics |
Nuremberg was for nazis only and UK is not Europe
32218549 2020. Should scientists infect healthy people with the coronavirus to test vaccines?
32241929 2020. Infect volunteers to speed a coronavirus vaccine?
32322034 2020. Hundreds of people volunteer to be infected with coronavirus.
32461245 2020. Ethical guidelines for deliberately infecting volunteers with COVID-19.
32469074 2020. Paying Participants in COVID-19 Trials.
32414757 2020. Ethical considerations for epidemic vaccine trials.
32479747 2020. COVID-19 human challenge studies: ethical issues.
32496536 2020. SARS-CoV-2 Human Challenge Trials: Too Risky, Too Soon.
32635912 2020. Exploring the acceptability of controlled human infection with SARSCoV2-a public consultation.
32669462 2020. Human Infection Challenge Studies: a Test for the Social Value Criterion of Research Ethics.
32616623 2020. Controlled human infection with SARS-CoV-2 to study COVID-19 vaccines and treatments: bioethics in Utopia.
32795408 2020. Evolving ethics of COVID-19 challenge trials.
32851596 2020. COVID-19 vaccines: ethical framework concerning human challenge studies.
32829985 2020. SARS-CoV-2 controlled human infection models: Ethics, challenge agent production and regulatory issues.
32840856 2020. Coronavirus Human Infection Challenge Studies: Assessing Potential Benefits and Risks.
33046591 2020. Payment of COVID-19 challenge trials: underpayment is a bigger worry than overpayment.
32978304 2020. SARS-CoV-2 challenge studies: ethics and risk minimisation.
32978306 2020. Payment in challenge studies: ethics, attitudes and a new payment for risk model.
33082550 2020. Dozens to be deliberately infected with coronavirus in UK 'human challenge' trials.
33087558 2020. Opinion: A risk-benefit framework for human research during the COVID-19 pandemic.
33087904 2020. Immunological considerations for SARS-CoV-2 human challenge studies.
33122444 2020. Opinion: For now, it's unethical to use human challenge studies for SARS-CoV-2 vaccine development.
33137284 2020. COVID-19 human challenge studies in the UK.
33154089 2020. Should practice and policy be revised to allow for risk-proportional payment to human challenge study participants?
33235368 2020. The COVID vaccine challenges that lie ahead.
33236048 2020. Challenge Trials: What Are the Ethical Problems?
33249450 2020. Assessment of risks associated with SARS-CoV-2 experimental human infection studies.
C7598752 ?. Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group.
C7239090 ?. Why We (Probably) Must Deliberately Infect.
